Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli
Open Access
- 1 June 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (6), 2700-2701
- https://doi.org/10.1128/aac.00290-09
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2008
- Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care FacilitiesClinical Infectious Diseases, 2008
- Treatment of Recurrent Urosepsis with Tigecycline: a Pharmacological PerspectiveJournal of Clinical Microbiology, 2008
- In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care unitsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east EnglandJournal of Antimicrobial Chemotherapy, 2006
- In vitro activity of temocillin against extended spectrum β-lactamase-producing Escherichia coliJournal of Antimicrobial Chemotherapy, 2006
- BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humansAntimicrobial Agents and Chemotherapy, 1981